Glucagon and insulin secretion in potential diabetes

Area of Science:

• Endocrinology
• Metabolic Disorders
• Diabetes Research

Background:

• Family history of diabetes is a significant risk factor for developing type 2 diabetes.
• Prediabetes and impaired glucose tolerance represent early stages of metabolic dysfunction.
• Understanding hormonal regulation is crucial for early diabetes detection and intervention.

Purpose of the Study:

• To investigate insulin and glucagon secretion patterns in individuals with normal glucose tolerance ('true prediabetics') and impaired glucose tolerance ('genetic chemical diabetes').
• To compare hormonal responses to oral and intravenous glucose loads, as well as arginine infusion, between study groups and controls.
• To explore potential alterations in the control mechanisms of glucagon secretion in early diabetes phases.

Main Methods:

• Studied 20 subjects with a family history of diabetes, divided into 'true prediabetics' (10) and 'genetic chemical diabetes' (10).
• Administered oral glucose (100g), intravenous glucose (200mg/kg + 20mg/kg/min), and arginine infusion (25g) to assess hormonal responses.
• Measured insulin and glucagon levels and calculated the insulin/glucagon molar ratio post-stimulation.

Main Results:

• Insulin response was normal in prediabetics but delayed and elevated in chemical diabetes compared to controls.
• Glucagon response to arginine was slightly higher in both prediabetic and chemical diabetes groups, though not significantly.
• Crucially, glucagon suppression by glucose was absent in both prediabetic and chemical diabetes groups.
• The insulin/glucagon molar ratio was significantly reduced after glucose infusion in both groups.
• No correlation was observed between insulin and glucagon secretion after arginine or glucose challenges.

Conclusions:

• Individuals with 'true prediabetes' and 'genetic chemical diabetes' display distinct patterns of insulin and glucagon secretion.
• The lack of glucagon suppression by glucose in these groups suggests an early defect in glucagon regulation.
• These findings indicate a potential alteration in the mechanisms controlling glucagon secretion even in the earliest stages of diabetes development.